BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zada D, Tovin A, Lerer-Goldshtein T, Appelbaum L. Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafish. Dis Model Mech 2016;9:1339-48. [PMID: 27664134 DOI: 10.1242/dmm.027227] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Roberti A, Chaffey LE, Greaves DR. NF-κB Signaling and Inflammation-Drug Repurposing to Treat Inflammatory Disorders? Biology (Basel) 2022;11:372. [PMID: 35336746 DOI: 10.3390/biology11030372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Rozenblat R, Tovin A, Zada D, Lebenthal-Loinger I, Lerer-Goldshtein T, Appelbaum L. Genetic and Neurological Deficiencies in the Visual System of mct8 Mutant Zebrafish. Int J Mol Sci 2022;23:2464. [PMID: 35269606 DOI: 10.3390/ijms23052464] [Reference Citation Analysis]
3 van Geest FS, Gunhanlar N, Groeneweg S, Visser WE. Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development. Front Endocrinol (Lausanne) 2021;12:723750. [PMID: 34539576 DOI: 10.3389/fendo.2021.723750] [Reference Citation Analysis]
4 Farías-Serratos BM, Lazcano I, Villalobos P, Darras VM, Orozco A. Thyroid hormone deficiency during zebrafish development impairs central nervous system myelination. PLoS One 2021;16:e0256207. [PMID: 34403440 DOI: 10.1371/journal.pone.0256207] [Reference Citation Analysis]
5 Groeneweg S, van Geest FS, Peeters RP, Heuer H, Visser WE. Thyroid Hormone Transporters. Endocr Rev 2020;41:bnz008. [PMID: 31754699 DOI: 10.1210/endrev/bnz008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 30.0] [Reference Citation Analysis]
6 Vatine GD, Shelest O, Barriga BK, Ofan R, Rabinski T, Mattis VB, Heuer H, Svendsen CN. Oligodendrocyte progenitor cell maturation is dependent on dual function of MCT8 in the transport of thyroid hormone across brain barriers and the plasma membrane. Glia 2021;69:2146-59. [PMID: 33956384 DOI: 10.1002/glia.24014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang Y, Hamid N, Jia P, Pei D. A comprehensive review on genetically modified fish: key techniques, applications and future prospects. Rev Aquacult 2021;13:1635-60. [DOI: 10.1111/raq.12538] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Huntemer-Silveira A, Patil N, Brickner MA, Parr AM. Strategies for Oligodendrocyte and Myelin Repair in Traumatic CNS Injury. Front Cell Neurosci 2020;14:619707. [PMID: 33505250 DOI: 10.3389/fncel.2020.619707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Braun D, Schweizer U. The Protein Translocation Defect of MCT8L291R Is Rescued by Sodium Phenylbutyrate. Eur Thyroid J 2020;9:269-80. [PMID: 33088796 DOI: 10.1159/000507439] [Reference Citation Analysis]
10 Vancamp P, Demeneix BA, Remaud S. Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination? Front Endocrinol (Lausanne) 2020;11:283. [PMID: 32477268 DOI: 10.3389/fendo.2020.00283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
11 Grijota-Martínez C, Bárez-López S, Gómez-Andrés D, Guadaño-Ferraz A. MCT8 Deficiency: The Road to Therapies for a Rare Disease. Front Neurosci 2020;14:380. [PMID: 32410949 DOI: 10.3389/fnins.2020.00380] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
12 Gothié JD, Vancamp P, Demeneix B, Remaud S. Thyroid hormone regulation of neural stem cell fate: From development to ageing. Acta Physiol (Oxf) 2020;228:e13316. [PMID: 31121082 DOI: 10.1111/apha.13316] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
13 Admati I, Wasserman-bartov T, Tovin A, Rozenblat R, Blitz E, Zada D, Lerer-goldshtein T, Appelbaum L. Neural Alterations and Hyperactivity of the Hypothalamic–Pituitary–Thyroid Axis in Oatp1c1 Deficiency. Thyroid 2020;30:161-74. [DOI: 10.1089/thy.2019.0320] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
14 Naef V, Mero S, Fichi G, D'Amore A, Ogi A, Gemignani F, Santorelli FM, Marchese M. Swimming in Deep Water: Zebrafish Modeling of Complicated Forms of Hereditary Spastic Paraplegia and Spastic Ataxia. Front Neurosci 2019;13:1311. [PMID: 31920481 DOI: 10.3389/fnins.2019.01311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
15 Groeneweg S, Kersseboom S, van den Berge A, Dolcetta-Capuzzo A, van Geest FS, van Heerebeek REA, Arjona FJ, Meima ME, Peeters RP, Visser WE, Visser TJ. In Vitro Characterization of Human, Mouse, and Zebrafish MCT8 Orthologues. Thyroid 2019;29:1499-510. [PMID: 31436139 DOI: 10.1089/thy.2019.0009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
16 Groeneweg S, Peeters RP, Moran C, Stoupa A, Auriol F, Tonduti D, Dica A, Paone L, Rozenkova K, Malikova J, van der Walt A, de Coo IFM, McGowan A, Lyons G, Aarsen FK, Barca D, van Beynum IM, van der Knoop MM, Jansen J, Manshande M, Lunsing RJ, Nowak S, den Uil CA, Zillikens MC, Visser FE, Vrijmoeth P, de Wit MCY, Wolf NI, Zandstra A, Ambegaonkar G, Singh Y, de Rijke YB, Medici M, Bertini ES, Depoorter S, Lebl J, Cappa M, De Meirleir L, Krude H, Craiu D, Zibordi F, Oliver Petit I, Polak M, Chatterjee K, Visser TJ, Visser WE. Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial. Lancet Diabetes Endocrinol 2019;7:695-706. [PMID: 31377265 DOI: 10.1016/S2213-8587(19)30155-X] [Cited by in Crossref: 49] [Cited by in F6Publishing: 25] [Article Influence: 16.3] [Reference Citation Analysis]
17 Senese R, Cioffi F, Petito G, Goglia F, Lanni A. Thyroid hormone metabolites and analogues. Endocrine 2019;66:105-14. [DOI: 10.1007/s12020-019-02025-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Diamantopoulou E, Baxendale S, de la Vega de León A, Asad A, Holdsworth CJ, Abbas L, Gillet VJ, Wiggin GR, Whitfield TT. Identification of compounds that rescue otic and myelination defects in the zebrafish adgrg6 (gpr126) mutant. Elife 2019;8:e44889. [PMID: 31180326 DOI: 10.7554/eLife.44889] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
19 Hernández-Linares Y, Olvera A, Villalobos P, Lozano-Flores C, Varela-Echavarría A, Luna M, Orozco A. 3,5-T2 and 3,3',5-T3 Regulate Cerebellar Thyroid Hormone Signalling and Myelin Molecular Dynamics in Tilapia. Sci Rep 2019;9:7359. [PMID: 31089165 DOI: 10.1038/s41598-019-43701-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Walter KM, Miller GW, Chen X, Yaghoobi B, Puschner B, Lein PJ. Effects of thyroid hormone disruption on the ontogenetic expression of thyroid hormone signaling genes in developing zebrafish (Danio rerio). Gen Comp Endocrinol 2019;272:20-32. [PMID: 30448381 DOI: 10.1016/j.ygcen.2018.11.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
21 Vancamp P, Houbrechts AM, Darras VM. Insights from zebrafish deficiency models to understand the impact of local thyroid hormone regulator action on early development. Gen Comp Endocrinol 2019;279:45-52. [PMID: 30244055 DOI: 10.1016/j.ygcen.2018.09.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
22 Vancamp P, Darras VM. From zebrafish to human: A comparative approach to elucidate the role of the thyroid hormone transporter MCT8 during brain development. General and Comparative Endocrinology 2018;265:219-29. [DOI: 10.1016/j.ygcen.2017.11.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
23 Bárez-López S, Hartley MD, Grijota-Martínez C, Scanlan TS, Guadaño-Ferraz A. Sobetirome and its Amide Prodrug Sob-AM2 Exert Thyromimetic Actions in Mct8-Deficient Brain. Thyroid 2018;28:1211-20. [PMID: 29845892 DOI: 10.1089/thy.2018.0008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
24 Groeneweg S, van den Berge A, Meima ME, Peeters RP, Visser TJ, Visser WE. Effects of Chemical Chaperones on Thyroid Hormone Transport by MCT8 Mutants in Patient-Derived Fibroblasts. Endocrinology 2018;159:1290-302. [DOI: 10.1210/en.2017-00846] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
25 Marelli F, Persani L. How zebrafish research has helped in understanding thyroid diseases. F1000Res 2017;6:2137. [PMID: 29263787 DOI: 10.12688/f1000research.12142.1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
26 Zada D, Blitz E, Appelbaum L. Zebrafish – An emerging model to explore thyroid hormone transporters and psychomotor retardation. Molecular and Cellular Endocrinology 2017;459:53-8. [DOI: 10.1016/j.mce.2017.03.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
27 Groeneweg S, Peeters RP, Visser TJ, Visser WE. Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes. Molecular and Cellular Endocrinology 2017;458:82-90. [DOI: 10.1016/j.mce.2017.02.029] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
28 Silva N, Louro B, Trindade M, Power DM, Campinho MA. Transcriptomics reveal an integrative role for maternal thyroid hormones during zebrafish embryogenesis. Sci Rep 2017;7:16657. [PMID: 29192226 DOI: 10.1038/s41598-017-16951-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
29 Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet 2017;390:2481-9. [PMID: 29029896 DOI: 10.1016/S0140-6736(17)32346-2] [Cited by in Crossref: 191] [Cited by in F6Publishing: 98] [Article Influence: 38.2] [Reference Citation Analysis]
30 Gut P, Reischauer S, Stainier DYR, Arnaout R. LITTLE FISH, BIG DATA: ZEBRAFISH AS A MODEL FOR CARDIOVASCULAR AND METABOLIC DISEASE. Physiol Rev 2017;97:889-938. [PMID: 28468832 DOI: 10.1152/physrev.00038.2016] [Cited by in Crossref: 137] [Cited by in F6Publishing: 114] [Article Influence: 27.4] [Reference Citation Analysis]
31 Cole KLH, Early JJ, Lyons DA. Drug discovery for remyelination and treatment of MS. Glia 2017;65:1565-89. [PMID: 28618073 DOI: 10.1002/glia.23166] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
32 Groeneweg S, Peeters RP, Visser TJ, Visser WE. Triiodothyroacetic acid in health and disease. J Endocrinol 2017;234:R99-R121. [PMID: 28576869 DOI: 10.1530/JOE-17-0113] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 7.8] [Reference Citation Analysis]
33 Levitas-Djerbi T, Appelbaum L. Modeling sleep and neuropsychiatric disorders in zebrafish. Curr Opin Neurobiol 2017;44:89-93. [PMID: 28414966 DOI: 10.1016/j.conb.2017.02.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]